HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Shanthi Marur Selected Research
Shanthi Marur Research Topics
Disease
11
Neoplasms (Cancer)
01/2023 - 07/2009
10
Squamous Cell Carcinoma of Head and Neck
01/2023 - 04/2008
4
Squamous Cell Neoplasms (Squamous Cell Cancer)
03/2016 - 04/2008
3
Oropharyngeal Neoplasms
05/2012 - 08/2010
3
Fistula
04/2011 - 01/2011
3
Wounds and Injuries (Trauma)
04/2011 - 01/2011
2
Disease Progression
01/2018 - 07/2009
2
Neutropenia
02/2016 - 02/2014
2
Head and Neck Neoplasms (Head and Neck Cancer)
01/2015 - 06/2013
2
Anaplastic Thyroid Carcinoma
02/2014 - 12/2012
1
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2018
1
Squamous Cell Carcinoma (Epidermoid Carcinoma)
02/2017
1
Sepsis (Septicemia)
02/2016
1
Diarrhea
02/2016
1
Pancytopenia
02/2016
1
Pneumonia (Pneumonitis)
02/2016
1
Abdominal Pain (Pain, Abdominal)
02/2016
1
Hypersensitivity (Allergy)
01/2015
1
Exanthema (Rash)
01/2015
1
Arthralgia (Joint Pain)
01/2015
1
Edema (Dropsy)
01/2015
1
Hypertension (High Blood Pressure)
02/2014
1
Nasopharyngeal Neoplasms (Cancer of the Nasopharynx)
06/2013
1
Infections
12/2012
1
Neoplasm Metastasis (Metastasis)
11/2012
1
Mucositis
05/2012
1
Carcinoma (Carcinomatosis)
05/2011
1
Laryngeal Neoplasms (Laryngeal Cancer)
01/2011
1
Thyroid Neoplasms (Thyroid Cancer)
08/2009
1
Prostatic Neoplasms (Prostate Cancer)
07/2009
1
Pain (Aches)
07/2009
1
Renal Cell Carcinoma (Grawitz Tumor)
10/2008
1
Kidney Neoplasms (Kidney Cancer)
10/2008
Drug/Important Bio-Agent (IBA)
3
Docetaxel (Taxotere)
FDA Link
01/2018 - 10/2008
3
Cetuximab (Erbitux)
FDA Link
01/2018 - 01/2016
3
Platinum
IBA
01/2018 - 06/2013
3
ErbB Receptors (EGF Receptor)
IBA
01/2016 - 04/2008
2
Tadalafil (Cialis)
FDA Link
12/2018 - 01/2015
2
Biomarkers (Surrogate Marker)
IBA
01/2018 - 07/2009
2
Paclitaxel (Taxol)
FDA Link
Generic
02/2016 - 02/2014
2
Carboplatin (JM8)
FDA Link
Generic
02/2016 - 02/2014
2
fosbretabulin (combretastatin A4)
IBA
02/2014 - 12/2012
2
Capecitabine (Xeloda)
FDA Link
07/2009 - 10/2008
1
Estrogen Receptor alpha
IBA
01/2023
1
TNF Receptor-Associated Factor 3
IBA
01/2023
1
Insulin-Like Growth Factor I (IGF-1)
IBA
01/2018
1
Cytokines
IBA
01/2018
1
Angiogenesis Inducing Agents (Angiogenesis Factor)
IBA
01/2018
1
cixutumumab
IBA
01/2018
1
B7-H1 Antigen
IBA
01/2018
1
Blocking Antibodies
IBA
01/2018
1
Afatinib
IBA
02/2016
1
Explosive Agents (Explosives)
IBA
01/2015
1
Steroids
IBA
01/2015
1
Phosphodiesterase 5 Inhibitors
IBA
01/2015
1
Type 5 Cyclic Nucleotide Phosphodiesterases
IBA
01/2015
1
Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)
FDA Link
12/2013
1
DNA-Directed RNA Polymerases (RNA Polymerase)
IBA
06/2013
1
Proteins (Proteins, Gene)
FDA Link
06/2013
1
1- (3- C- ethynylribopentofuranosyl)cytosine
IBA
06/2013
1
TOR Serine-Threonine Kinases
IBA
12/2012
1
Iodine
IBA
08/2009
1
Dihydrouracil Dehydrogenase (NADP) (Dihydropyrimidine Dehydrogenase)
IBA
07/2009
1
Thymidine
IBA
07/2009
1
Prostate-Specific Antigen (Semenogelase)
IBA
07/2009
1
Thymidine Phosphorylase
IBA
07/2009
Therapy/Procedure
8
Therapeutics
01/2023 - 04/2008
8
Drug Therapy (Chemotherapy)
01/2018 - 04/2008
3
Radiotherapy
03/2016 - 05/2012
2
Induction Chemotherapy
02/2017 - 02/2016
2
Neck Dissection (Radical Neck Dissection)
11/2012 - 01/2011
2
Mandibular Osteotomy
04/2011 - 04/2011
2
Glossectomy
04/2011 - 04/2011
2
Laryngectomy
01/2011 - 01/2011
1
Aftercare (After-Treatment)
12/2013
1
Thyroidectomy
12/2012
1
Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
05/2011
1
Pharyngectomy
04/2011
1
Length of Stay
01/2011